GGrantIndex
Sort

48,018 grants matching immunotherapy

Immune Response to RBC Antigens

$708,521
Krystalyn E Hudson · Columbia University Health Sciences · R01 · FY2025 · HL

Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study

$708,444
Allison W. Kurian · Stanford University · R01 · FY2024 · CA

The Molecular Profile of Prostate Tumors in African-American Men

$708,426
Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia

$708,255
Robert H Gilman · Johns Hopkins University · R01 · FY2022 · AI

T cells in the aging brain

$708,203
Anne Brunet · Stanford University · R01 · FY2025 · AG

A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead

$708,200
Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Targeting Protein Arginine Methyltransferases to Eradicate Acute Myeloid Leukemia

$708,057
Ling Li · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA

Diversity-focused Montefiore Einstein Clinical Oncology Training Program in the Bronx

$707,995
Amit Verma · Albert Einstein College Of Medicine · K12 · FY2024 · CA

Development of a platform for spatial functional genomics

$707,878
Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AT

Development of a Clinical CEST MR Fingerprinting Method for Treatment Response Assessment in Brain Metastases

$707,865
Ouri Cohen · Sloan-Kettering Inst Can Research · R37 · FY2022 · CA

Mechanisms for initiation of food allergy early in life

$707,842
Joan M Cook-Mills · Indiana University Indianapolis · R01 · FY2020 · AI

Defining the Inflammation and Immunity Transcriptome in Severe Malarial Anemia for Immunotherapeutic Discovery

$707,737
Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2021 · AI

Tousled like kinase signaling in cancer

$707,584
Travis Stracker · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Lymphoma Studies

$707,482
Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA

Population Modeling of Bladder Cancer Detection and Control

$707,395
Thomas Trikalinos · Brown University · U01 · FY2021 · CA

Product for sensitive imaging of cells in vivo

$707,370
Brooke Helfer · Celsense, Inc. · R44 · FY2020 · EB

Development of a PET Tracer Selective for Cerebral Amyloid Angiopathy

$707,295
Milos D Ikonomovic · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AG

Novel Cellular Therapies for Ph+ leukemia

$707,089
Richard A. Van Etten · Tufts Medical Center · R01 · FY2009 · HL

Project 3: Hyperimmune globulin prophylaxis and treatment of ZIKV in pregnancy

$706,847
David H Oconnor · University Of Wisconsin-Madison · P01 · FY2020 · AI

Regulation of RANTES expression in T lymphocytes

$706,570
Alan Krensky · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Function of granulysin

$706,570
Alan Krensky · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

NOVEL NANO-PHOTO-IMMUNOTHERAPY AGAINST OVARIAN CANCER

$706,500
University Of California, Davis · · FY2019 · Department of the Army

Immunotherapy to deplete key Treg subsets in solid tumors

$706,495
Peter David Suzdak · Sonoval Llc · R44 · FY2025 · CA

Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy

$706,425
Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2022 · CA

Metabolic Impacts of Type II Interferon Signals in Obesity

$706,144
Sean Hartig · Baylor College Of Medicine · R01 · FY2024 · DK